Literature DB >> 24727821

Red blood cell immunization in sickle cell disease: evidence of a large responder group and a low rate of anti-Rh linked to partial Rh phenotype.

Monique Silvy1, Christophe Tournamille2, Jérôme Babinet3, Sadaf Pakdaman2, Sylvain Cohen3, Jacques Chiaroni1, Frédéric Galactéros4, Philippe Bierling2, Pascal Bailly5, France Noizat-Pirenne6.   

Abstract

Keywords:  frequencies of RH allele variants; sickle cell disease; transfusion strategy

Mesh：

Substances：

Year:  2014        PMID： 24727821      PMCID： PMC4077098          DOI： 10.3324/haematol.2014.104703

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  11 in total

1.  Rare RHCE phenotypes in black individuals of Afro-Caribbean origin: identification and transfusion safety.

Authors:  France Noizat-Pirenne; Ketty Lee; Pierre-Yves Le Pennec; Philippe Simon; Philippe Kazup; Dora Bachir; Anne-Marie Rouzaud; Michele Roussel; Geneviève Juszczak; Cècile Ménanteau; Philippe Rouger; Rami Kotb; Jean-Pierre Cartron; Hélène Ansart-Pirenne
Journal:  Blood       Date:  2002-08-01       Impact factor: 22.113

2.  Transfusion practices for patients with sickle cell disease at major academic medical centers participating in the Atlanta Sickle Cell Consortium.

Authors:  A M Winkler; C D Josephson
Journal:  Immunohematology       Date:  2012

3.  Red cell alloimmunization in sickle-cell anaemia patients.

Authors:  L A M Bashawri
Journal:  East Mediterr Health J       Date:  2007 Sep-Oct       Impact factor: 1.628

4.  Identification of RHCE and KEL alleles in large cohorts of Afro-Caribbean and Comorian donors by multiplex SNaPshot and fragment assays: a transfusion support for sickle cell disease patients.

Authors:  Monique Silvy; Julie Di Cristofaro; Sophie Beley; Kassim Papa; Michel Rits; Pascale Richard; Jacques Chiaroni; Pascal Bailly
Journal:  Br J Haematol       Date:  2011-05-28       Impact factor: 6.998

5.  Antibody of undetermined specificity: frequency, laboratory features, and natural history.

Authors:  Chang Liu; Brenda J Grossman
Journal:  Transfusion       Date:  2013-01-11       Impact factor: 3.157

6.  The sickle cell hemolytic transfusion reaction syndrome.

Authors:  L D Petz; L Calhoun; I A Shulman; C Johnson; R M Herron
Journal:  Transfusion       Date:  1997-04       Impact factor: 3.157

7.  Red blood cell phenotype matching for various ethnic groups.

Authors:  Karafa S W Badjie; Craig D Tauscher; Camille M van Buskirk; Clare Wong; Sarah M Jenkins; Carin Y Smith; James R Stubbs
Journal:  Immunohematology       Date:  2011

Review 8.  Delayed hemolytic transfusion reaction in sickle cell disease.

Authors:  Leslie P Scheunemann; Kenneth I Ataga
Journal:  Am J Med Sci       Date:  2010-03       Impact factor: 2.378

9.  Stochastic modeling of human RBC alloimmunization: evidence for a distinct population of immunologic responders.

Authors:  John M Higgins; Steven R Sloan
Journal:  Blood       Date:  2008-06-05       Impact factor: 22.113

Review 10.  Red blood cell alloimmunization in sickle cell disease: pathophysiology, risk factors, and transfusion management.

Authors:  Karina Yazdanbakhsh; Russell E Ware; France Noizat-Pirenne
Journal:  Blood       Date:  2012-05-04       Impact factor: 22.113
View more
  11 in total

1.  TIGIT-positive circulating follicular helper T cells and sickle cell alloimmunization.

Authors:  France Pirenne
Journal:  Haematologica       Date:  2015-11       Impact factor: 9.941

2.  Rhesus pieces: genotype matching of RBCs.

Authors:  Jeanne E Hendrickson; Christopher A Tormey
Journal:  Blood       Date:  2018-09-13       Impact factor: 22.113

3.  Red blood cell alloimmunization is influenced by the delay between Toll-like receptor agonist injection and transfusion.

Authors:  Rahma Elayeb; Marie Tamagne; Philippe Bierling; France Noizat-Pirenne; Benoît Vingert
Journal:  Haematologica       Date:  2015-10-01       Impact factor: 9.941

4.  Diversity of RH and transfusion support in Brazilian sickle cell disease patients with unexplained Rh antibodies.

Authors:  Carla L Dinardo; Shannon Kelly; Marcia R Dezan; Ingrid H Ribeiro; Shirley L Castilho; Luciana C Schimidt; Maria do C Valgueiro; Liliana R Preiss; Brian Custer; Ester C Sabino; Connie M Westhoff
Journal:  Transfusion       Date:  2019-08-13       Impact factor: 3.157

Review 5.  How to avoid the problem of erythrocyte alloimmunization in sickle cell disease.

Authors:  France Pirenne; Aline Floch; Anoosha Habibi
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2021-12-10

Review 6.  How I safely transfuse patients with sickle-cell disease and manage delayed hemolytic transfusion reactions.

Authors:  France Pirenne; Karina Yazdanbakhsh
Journal:  Blood       Date:  2018-05-03       Impact factor: 22.113

Review 7.  Genotyping in Sickle Cell Disease Patients: The French Strategy.

Authors:  Aline Floch; Christophe Tournamille; Btissam Chami; France Pirenne
Journal:  Transfus Med Hemother       Date:  2018-07-06       Impact factor: 3.747

8.  Severe hemolytic transfusion reaction due to anti-D in a D+ patient with sickle cell disease.

Authors:  Tina S Ipe; Jennifer J Wilkes; Helge D Hartung; Connie M Westhoff; Stella T Chou; David F Friedman
Journal:  J Pediatr Hematol Oncol       Date:  2015-03       Impact factor: 1.289

9.  Alloimmunization in patients with sickle cell disease and underrecognition of accompanying delayed hemolytic transfusion reactions.

Authors:  Sarita Coleman; Connie M Westhoff; David F Friedman; Stella T Chou
Journal:  Transfusion       Date:  2019-04-25       Impact factor: 3.157

10.  Changing practice: red blood cell typing by molecular methods for patients with sickle cell disease.

Authors:  Jessica Casas; David F Friedman; Tannoa Jackson; Sunitha Vege; Connie M Westhoff; Stella T Chou
Journal:  Transfusion       Date:  2015-01-09       Impact factor: 3.157
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.